-
Medical journals
- Career
Czech and Slovak Pharmacy - Issue 6/2023
255
Review Articles
256267Brief insight into the in silico properties, structure–activity relationships and biotransformation of fruquintinib, an anticancer drug of a new generation containing a privileged benzofuran scaffoldDominika Nádaská, Lucia Hudecova, Gustáv Kováč, Ivan Malík
Original Articles
277Potential impact on mental health in patients with treatment-resistant schizophrenia – clozapine augmentation with long-acting parenteral antipsychotics: a case seriesM. Nováková, T. Hammer, E. Nováková, M. Mayerová, L. Ustohal, PharmDr. Bc. Hana Kotolová, Ph.D.
287Prospects of сomplex pharmaceutical composition application for pharmacological correction of metabolic syndromeKateryna Kalko, Nadia Dukhnich, Oksana Mishchenko, Viktor Khomenko, Olena Toziuk
297Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndromeLyudmila Kravchenko, Liana Unhurian, Svetlana K Tiuzhinska, Yana Ivanova, Maya Obrazenko, Liudmyla Zahorodnya, Tetiana Yamilova
304Analysis of medication administration in relation to food and beverages in inpatientsOndřej Tesař, Josef Malý, Lucie Malečová, Kateřina Malá-Ládová, Martin Doseděl, Iva Brabcová, Martin Červený, Radka Prokešová, Hana Hajduchová, Ivana Chloubová, Valérie Tóthová, Jiří Vlček
History of Pharmacy
312On the history and development of some changes in pharmacy practice – work safety in pharmaciesJozef Kolář, Tünde Ambrus
317Beauty in books: pharmaceutical bookplates in the territory of the present Czech RepublicLadislav Svatoš, Ladislava Valášková
Czech and Slovak Pharmacy
2023 Issue 6
Most read in this issue- Analysis of medication administration in relation to food and beverages in inpatients
- Potential impact on mental health in patients with treatment-resistant schizophrenia – clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Ethical aspects of conducting clinical trials of human medicinal products
- Brief insight into the in silico properties, structure–activity relationships and biotransformation of fruquintinib, an anticancer drug of a new generation containing a privileged benzofuran scaffold
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career